What is Bristol-Myers Squibb's net change in cash?

Bristol-Myers Squibb (BMY) reported net change in cash of -$635M in Q1 2026.

How has Bristol-Myers Squibb's net change in cash changed year-over-year?

Bristol-Myers Squibb's net change in cash decreased by 220.3% year-over-year, from $528M to -$635M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Bristol-Myers Squibb BMY Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Johnson & JohnsonJNJ

$1.98B-86.2%

Merck & Co.MRK

-$9.29B-103%

IncyteINCY

$363.28M+43.1%

Gilead SciencesGILD

$65M+103%

Oruka Therapeutics, Inc.ORKA

$2.59M-88.2%

Other financials

Income statement

See full

Revenue$11.5B+2.6%

Gross profit$8.1B-1.2%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

See full

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

See full

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

See full

Market cap$117.46B+22.7%

Enterprise value$152.54B+15.1%

P/E16.2×-3.1×

P/S2.4×+0.4×

Profitability

See full

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

See full

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's net change in cash?: Bristol-Myers Squibb (BMY) reported net change in cash of -$635M in Q1 2026.
How has Bristol-Myers Squibb's net change in cash changed year-over-year?: Bristol-Myers Squibb's net change in cash decreased by 220.3% year-over-year, from $528M to -$635M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.